| Identification | Back Directory | [Name]
(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole | [CAS]
886230-75-7 | [Synonyms]
Axitinib Impurity 54
Axitinib Intermediate 2
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran...
6-nitro-3-[(E)-2-(2-pyridyl)vinyl]-1-tetrahydropyran-2-yl-indazol e
(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)
6-nitro-3-(E)-2-pyridin-2-yl-vinyl)-1-
(tetrahydropyran-2-yl)-1H-indazole
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
1H-Indazole, 6-nitro-3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)- | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C19H18N4O3 | [MDL Number]
MFCD19440924 | [MOL File]
886230-75-7.mol | [Molecular Weight]
350.37 |
| Chemical Properties | Back Directory | [Boiling point ]
570.9±50.0 °C(Predicted) | [density ]
1.36 | [storage temp. ]
Sealed in dry,2-8°C | [pka]
4.20±0.10(Predicted) | [InChI]
InChI=1S/C19H18N4O3/c24-23(25)15-8-9-16-17(10-7-14-5-1-3-11-20-14)21-22(18(16)13-15)19-6-2-4-12-26-19/h1,3,5,7-11,13,19H,2,4,6,12H2/b10-7+ | [InChIKey]
BKXMYFOISYYOLE-JXMROGBWSA-N | [SMILES]
N1(C2OCCCC2)C2=C(C=CC([N+]([O-])=O)=C2)C(/C=C/C2=NC=CC=C2)=N1 |
|
|